ArticleWorld journal of urology2021

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.

Wojciech Krajewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.